Clinical characteristics of coronary drug-eluting stent fracture: Insights from a two-center DES registry

Journal of Korean Medical Science

Volumn 26, Issue 1, 2011, Pages 53-58

  Park, Kyung Woo ^a   Park, Jin Joo ^a   Chae, In Ho ^b   Seo, Jae Bin ^a   Yang, Han Mo ^a   Lee, Hae Young ^a   Kang, Hyun Jae ^a   Cho, Young Seok ^b   Yeon, Tae Jin ^b   Chung, Woo Young ^c   Koo, Bon Kwon ^a   Choi, Dong Ju ^b   Oh, Byung Hee ^a   Park, Young Bae ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Clinical outcome; DES fracture; In stent restenosis; Risk factors; Target vessel revascularization

Indexed keywords

CARDIOVASCULAR AGENT; PACLITAXEL; RAPAMYCIN;

AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSTHESIS FAILURE; RADIOGRAPHY; REGISTER; RESTENOSIS; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; CARDIOVASCULAR AGENTS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSTHESIS FAILURE; REGISTRIES; RISK FACTORS; SEX FACTORS; SIROLIMUS;

EID: 78650789397     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.1.53     Document Type: Article

References (20)

1. Shaikh F, Maddikunta R, Djelmami-Hani M, Solis J, Allaqaband S, Bajwa T. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis? Catheter Cardiovasc Interv 2008; 71: 614-8.
2. Betriu A, Masotti M, Serra A, Alonso J, Fernández-Avilés F, Gimeno F, Colman T, Zueco J, Delcan JL, Garcia E, Calabuig J. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year followup. J Am Coll Cardiol 1999; 34: 1498-506.
3. Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J 2004; 147: 815-22.
4. Bae JH, Hyun DW, Kim KY, Yoon HJ, Nakamura S. Drug-eluting stent strut fracture as a cause of restenosis. Korean Circ J 2005; 35: 787-9.
5. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, Shim BS. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 2007; 100: 627-30.
6. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Aoki J, Franklin-Bond T, Dasgupta N, Lansky AJ, Dangas GD, Stone GW, Moses JW, Mehran R, Leon MB. Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol 2009; 103: 818-23.
7. Jaff M, Dake M, Pompa J, Ansel G, Yoder T. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices. Catheter Cardiovasc Interv 2007; 70: 460-2.
8. Yang TH, Kim DI, Park SG, Seo JS, Cho HJ, Seol SH, Kim SM, Kim DK, Kim DS. Clinical characteristics of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009; 131: 212-6.
9. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, Inagaki H, Toyama J, Yokota M, Murohara T. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009; 133: 321-6.
10. Sianos G, Hofma S, Ligthart JM, Saia F, Hoye A, Lemos PA, Serruys PW. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv 2004; 61: 111-6.
11. Kim EJ, Rha SW, Wani SP, Suh SY, Choi CU, Kim JW, Park CG, Seo HS, Oh DJ. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management? Int J Cardiol 2007; 120: 417-9.
12. Lee HS, Hur SH, Nam CW, Cho YK, Kim H, Han SW, Kim KB, Kim YN. A case of stent strut fracture of a paclitaxel-eluting stent at the time of sent implantation in a complex coronary lesion. Korean Circ J 2008; 38: 387-9.
13. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv 2007; 69: 387-94.
14. Makaryus AN, Lefkowitz L, Lee AD. Coronary artery stent fracture. Int J Cardiovasc Imaging 2007; 23: 305-9.
15. Park JS, Cho IH, Kim YJ. Stent fracture and restenosis after zotarolimuseluting stent implantation. Int J Cardiol 2009; doi:10.1016/j.ijcard.2009. 01.030.
16. Chung WS, Park CS, Seung KB, Kim PJ, Lee JM, Koo BK, Jang YS, Yang JY, Yoon JH, Kim DI, Yoon YW, Park JS, Cho YH, Park SJ. The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation. Int J Cardiol 2008; 125: 325-31.
17. Kim HS, Kim YH, Lee SW, Park DW, Lee CW, Hong MK, Park SW, Ko JK, Park JH, Lee JH, Choi SW, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Park SJ. Long-DES-II study investigators. Incidence and predictors of drug-eluting stent fractures in long coronary disease. Int J Cardiol 2009; 133: 354-8.
18. Canan T, Lee MS. Drug-eluting stent fracture: incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv 2010; 75: 237-45.
19. Liao R, Green NE, Chen SY, Messenger JC, Hansgen AR, Groves BM, Carroll JD. Three-dimensional analysis of in vivo coronary stent--coronary artery interactions. Int J Cardiovasc Imaging 2004; 20: 305-13.
20. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol 2009; 54: 1924-31.